Cell Source, Inc. (CLCS): Total Assets

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$286.5K
As of 2024-12-31
$292.4K
As of 2025-03-31
-3.0%
3-year compound annual growth
+20.1%
5-year compound annual growth
$531.7K2013-12-31: $92.2K2014-12-31: $123.1K2015-12-31: $214.8K2016-12-31: $211.1K2017-12-31: $531.7K2018-12-31: $65.8K2019-12-31: $114.8K2020-12-31: $452.3K2021-12-31: $313.8K2022-12-31: $409.8K2023-12-31: $195.2K2024-12-31: $286.5K$286.5K
2013-12-31 Total Assets (USD) 2024-12-31
Period endedTotal AssetsChange YoYSource filing
2024-12-31$286.5K+46.8%2026-04-07, Balance as of period end
2023-12-31$195.2K-52.4%2026-04-07, Balance as of period end
2022-12-31$409.8K+30.6%2024-06-24, Balance as of period end
2021-12-31$313.8K-30.6%2023-08-08, Balance as of period end
2020-12-31$452.3K+294.1%2022-04-15, Balance as of period end
2019-12-31$114.8K+74.5%2021-04-15, Balance as of period end
2018-12-31$65.8K-87.6%2020-03-30, Balance as of period end
2017-12-31$531.7K+151.9%2019-04-01, Balance as of period end
2016-12-31$211.1K-1.7%2018-07-25, Balance as of period end
2015-12-31$214.8Kn/c2018-07-25, Balance as of period end
2014-12-31$123.1K+33.5%2016-04-14, Balance as of period end
2013-12-31$92.2Kn/a2015-03-13, Balance as of period end